ABBVIE SPAIN, S.L. secures contract for Pharmaceutical products Supply of Humira Adalimumab for continuation of treatments excluding the new treatments Venetoclax DOE and Dexamethasone DOE intravitrea

Spain, April 27 -- Spain based ABBVIE SPAIN, S.L. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products Supply of Humira Adalimumab for continuation of treatments excluding the new treatments Venetoclax DOE and Dexamethasone DOE intravitrea. The value of the contract is worth 363064620 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....